Qure.ai has received breakthrough device designation from the US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health for its artificial intelligence (AI)-powered TB solution, qSpot-TB. It is a second-read computer aided detection and diagnosis device that analyses chest X-rays to localize all noted radiological signs suggestive of TB and provide an accompanying conclusion regarding the presence or absence of TB.
Read more here.
Read the company announcement here.
For more TB news, check out the latest edition of the TB Online Weekly Newsletter (#5, 12 February 2024) with the latest TB advocacy and research updates.
Source : Health Imaging
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.